News Focus
News Focus
icon url

Amatuer17

09/08/18 9:44 PM

#28182 RE: misiu143 #28180

Misiu - some of the things you said is your interpretation of the conf call.

I have listened to P conf calls for 3 years - he mixes thing up and so I do not think we have clear answer.

You think FDA will considering converting current trials based on 325-550 mg dosing - I do not believe that - simply based on my reading and investing in biotech. A variable dosing in P2b does not give FDA sufficient confidence to approve one dose out of 2 as final dose.

The fact that P is trying 700 mg - I think he wants to go for big kill - reach 80-85% range.

Also - I do not think P has started 700 mg dosing - I hope I am wrong.

So no harm in asking the questions - I don’t think we will get any answers.